### Allegations Against Baxter International
Baxter International Inc. is currently facing a class action lawsuit initiated by the Schall Law Firm, which specializes in shareholder rights litigation. This legal action centers on allegations of securities fraud that breach sections 10(b) and 20(a) of the Securities Exchange Act of 1934, along with Rule 10b-5 as enforced by the U.S. Securities and Exchange Commission. Investors who purchased shares of Baxter between February 23, 2022, and July 30, 2025, are being encouraged to reach out to the law firm before the December 15, 2025, deadline to discuss their options for joining the lawsuit.
### Details of the Case
According to the complaint filed, Baxter misled the market with false statements regarding the safety and reliability of its Novum IQ Large Volume Pump (Novum LVP). The suit claims that the device experienced serious malfunctions, including issues with overinfusion and failure to deliver necessary fluids, which put patients at significant risk of injury or death. Despite being aware of these malfunctions and the associated injuries, the company reportedly failed to adequately rectify the underlying design flaws, leading to an increased chance of the pumps being withdrawn from service and new sales being halted.
As a result of these revelations, shareholders experienced a decline in the value of their investments when the truth about the company’s practices became public. The lawsuit aims to recover losses incurred by investors during this period and hold Baxter accountable for its alleged misrepresentations.
### Participation and Legal Rights
Interested investors are invited to join the class action to ensure their voices are heard. The Schall Law Firm has stated that until the class is certified, participants are not officially represented by an attorney. Consequently, investors who choose to remain inactive will be considered absent class members. For those who suffered financial losses, contacting the firm offers a chance to discuss legal options without any financial obligation. Investors can reach out to Brian Schall at the firm’s office in Los Angeles, or through their website for further assistance regarding their rights.
This lawsuit represents a significant opportunity for affected shareholders to seek justice and potentially recover their investments amid troubling circumstances surrounding Baxter International Inc. and its product safety policies. As the case develops, it will be pivotal in determining the accountability measures taken against the company in the wake of these serious allegations.
Related
